Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain.
Martínez-Lozano H, Miranda-Bautista J, González-Lama Y, Carpio D, Barreiro-de Acosta M, Pérez-Calle JL, Relea Pérez L, Villa K, Matallana V, Calvo M, Vera MI, Pérez Galindo P, Mora-Cuadrado N, López-Serrano P, Marín-Jiménez I, Menchén L.
Martínez-Lozano H, et al. Among authors: relea perez l.
Rev Esp Enferm Dig. 2021 Mar;113(3):170-178. doi: 10.17235/reed.2020.6847/2019.
Rev Esp Enferm Dig. 2021.
PMID: 33213166
Free article.